Category News

UN Biodiversity Negotiators To Work From Single Text On Access, Benefits

For the first time in its history, a working group tasked with negotiating an international regime for access to genetic resources and the sharing of related benefits under the UN Convention on Biological Diversity (CBD) has agreed on a single negotiating text. But participants in the process say the text, while a comprehensive compilation of all divergent views on the regime, still has a way to go before becoming a consensus document.

WTO GI Register Draft Report Sees Areas Of Convergence

The outgoing chair’s draft report on progress at the World Trade Organization toward establishing a mandated register for geographical indications praises recent work and sees hope for convergence on outstanding issues such as legal effects and participation, according to a copy obtained by Intellectual Property Watch. But it details key differences on the issues that remain.

Public Health Roundup: Progress Seen, Investment Needed

New business models might bring down vaccine prices and public-private partnerships could open the way to new treatments to deadly tropical diseases but some countries are lagging behind in their investments to reach their health targets, according to reports from public health organisations holding meetings in different parts of the world.

Coordination Tops Issues At WIPO Development Agenda Meeting

Deciding on a mechanism to ensure the effective implementation of the World Intellectual Property Organization Development Agenda will be the biggest area of discussion at this week’s WIPO meeting on IP and development, sources have said. But discussion also will focus on specific implementation projects.

Brazil Issues Retaliation List Of US Products; IP-Protected Items In Next Round

Brazil has announced the list of 222 American products that could suffer retaliation with tariff rates of more than 100 percent of the value when imported to Brazil. The list could be followed by another including potentially hundreds of millions of dollars in non-tariff items related to intellectual property rights such as lower-priced patented pharmaceuticals.